SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Atul’s arm gets EIR from USFDA for Ambernath facility

09 Aug 2024 Evaluate

Atul’s 100% subsidiary -- Atul Bioscience (ABL) has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility situated in Ambernath, Maharashtra. The EIR was issued post the last inspection of the facility conducted from May 06, 2024, to May 10, 2024 which concluded with zero FDA 483 observations.

Atul is one of the largest integrated chemical companies of India. The company has one of the biggest integrated chemical complexes in India with a well-diversified product portfolio of around products and formulations.


Atul Share Price

6554.15 -38.00 (-0.58%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3653.10
Tata Chemicals 704.05
SRF 2464.40
Pidilite Inds. 1390.15
Deepak Nitrite 1537.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×